FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Drug and Therapy Development for Triple Negative Breast Cancer

Pravin Kendrekar
    Product form
      FORMAT: Hardback

      R 5,453.00 Price and availability exclusive to website

      YOU COULD EARN 5,453 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 20 - 30 Business Days
      BUY NOW PAY LATER
      From R 908.83 per month!
      3x monthly payments of R 1,817.66 with
      4x fortnightly payments of R 1,363.25 with
      The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer In Drug and Therapy Development for Triple Negative Breast Cancer, a team of distinguished practitioners delivers an in-depth and authoritative discussion of contemporary methods for treating triple negative breast cancer (TNBC). The editors have included material that covers its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies—including nanotherapeutics and photothermal therapies. As the first comprehensive compilation of modern treatment methods for TNBC, this reference is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis. Readers will also find: A thorough introduction to HER receptors in breast cancersComprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancerNew developments in drug repurposing for the treatment of acute leukemia complicating metastatic breast cancerNew insights on the role of DNA replication stress and genome instability in breast cancer Perfect for medicinal and pharmaceutical chemists, Drug and Therapy Development for Triple Negative Breast Cancer will also benefit oncologists and professionals working in the pharmaceutical industry or in hospital settings.
      Format: Hardback CONTRIBUTORS: Pravin Kendrekar EAN: 9783527351756 COUNTRY: Germany PAGES: WEIGHT: 0 g HEIGHT: 244 cm
      PUBLISHED BY: Wiley-VCH Verlag GmbH DATE PUBLISHED: 2023-09-13 CITY: GENRE: WIDTH: 170 cm SPINE:

      Book Themes:

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Pravin Kendrekar works at the School of Natural Sciences in the University of Central Lancashire, Preston, UK. Vinayak Adimule works at the Angadi Institute of Technology and Management in Belagavi, India. Tara Hurst works in the School of Health Sciences at Birmingham City University in Edgbaston, UK.
      The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer In Drug and Therapy Development for Triple Negative Breast Cancer, a team of distinguished practitioners delivers an in-depth and authoritative discussion of contemporary methods for treating triple negative breast cancer (TNBC). The editors have included material that covers its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies—including nanotherapeutics and photothermal therapies. As the first comprehensive compilation of modern treatment methods for TNBC, this reference is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis. Readers will also find: A thorough introduction to HER receptors in breast cancersComprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancerNew developments in drug repurposing for the treatment of acute leukemia complicating metastatic breast cancerNew insights on the role of DNA replication stress and genome instability in breast cancer Perfect for medicinal and pharmaceutical chemists, Drug and Therapy Development for Triple Negative Breast Cancer will also benefit oncologists and professionals working in the pharmaceutical industry or in hospital settings.
      Format: Hardback CONTRIBUTORS: Pravin Kendrekar EAN: 9783527351756 COUNTRY: Germany PAGES: WEIGHT: 0 g HEIGHT: 244 cm
      PUBLISHED BY: Wiley-VCH Verlag GmbH DATE PUBLISHED: 2023-09-13 CITY: GENRE: WIDTH: 170 cm SPINE:

      Book Themes:

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Pravin Kendrekar works at the School of Natural Sciences in the University of Central Lancashire, Preston, UK. Vinayak Adimule works at the Angadi Institute of Technology and Management in Belagavi, India. Tara Hurst works in the School of Health Sciences at Birmingham City University in Edgbaston, UK.

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account